Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus

Clinical Infectious Diseases

Volumn 24, Issue 5, 1997, Pages 836-840

  Gerard L ^b   Leport, C ^a   Flandre, P ^b   Houhou, N ^b   Salmon Ceron ^b   Pepin J M ^b   Mandet, C ^a   Brun Vezinet F ^b   Vilde J L ^b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; CHILD; CYTOMEGALOVIRUS INFECTION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; VIREMIA;

EID: 0030988954     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.5.836     Document Type: Article

References (24)

1. Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992;14:608-15.
2. Harb GE, Bacchetti P, Jacobson MA. Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscamet. AIDS 1991;5:959-65.
3. Macher AM, Reichert CM, Straus SE, et al. Death in the AIDS patient: role of cytomegalovirus [letter]. N Engl J Med 1983;309:1454.
4. Collier AC, Meyers JD, Corey L, Murphy VL, Roberts PL, Handsfield HH. Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunology. Am J Med 1987;82(spec no.):593-601.
5. Salmon-Céron D, Colasante U, Carré N, et al. Is HIV disease progression influenced by CMV co-infection? [abstract PB0018]. In: Program and abstracts of the 10th International Conference on AIDS (Yokohama, Japan). New York: Karger, 1994.
6. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992;5:1069-74.
7. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE, the Zidovudine Epidemiology Study Group. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992;166:223-7.
8. Salmon D, Lacassin F, Harzic M, et al. Predictive value of cytomegalovirus viremia for the occurrence of CMV organ involvement in AIDS. J Med Virol 1990;32:160-3.
9. Mentec H, Leport C, Leport J, Marche C, Harzic M, Vildé JL. Cytomegalovirus colitis in HIV-1-infected patients: a prospective research in 55 patients. AIDS 1994;8:461-7.
10. Masur H, Whitcup SM, Cartwright C, Polis M, Nussenblatt R. Advances in the management of AIDS-related cytomegalovirus retinitis. Ann Intern Med 1996;125:126-36.
11. Pepin JM, Simon M, Simon F, Dazza MC, Brun-Vezinet F. Comparison of two methods for rapid detection of cytomegalovirus viremia in cell culture. Res Virol 1991;142:443-8.
12. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. Journal of the American Statistical Association 1958;53:457-81.
13. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. Journal of the Royal Statistical Society A 1972;135:185-206.
14. Cox DR. Regression models and life tables. Journal of the Royal Statistical Society B 1972;34:187-202.
15. Zurlo JJ, O'Neill D, Polis MA, et al. Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Intern Med 1993;118:12-7.
16. Reiter WM, Cimoch PJ, Keller RH. How useful are cytomegalovirus cultures in patients with HIV infection? [letter]. Ann Intern Med 1993;119:247-8.
17. Dubé MP, Sattler FR. How useful are cytomegalovims cultures in patients with HIV infection? [letter]. Ann Intern Med 1993;119:248.
18. Goodrich JM, Mori M, Cleaves CA, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991;325:1601-7.
19. Fiala M, Cone LA, Chang CM, Mocarski ES. Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III. AIDS Res 1986;2:175-81,
20. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. N Engl J Med 1992;326:213-20.
21. Spector SA, McKinley GF, Lalezari JP, et al. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N Engl J Med 1996;334:1491-7.
22. Van der Bif W, Schirm J, Torensma W, van Son J, Tegzess AM, The TH. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol 1988;26:2531-5.
23. Einsele H, Ehninger G, Hebart H, et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995;86:2815-20.
24. Rasmussen L, Morris S, Zipeto D, et al. Quantification of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J Infect Dis 1995;171:177-82.